Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemostatic Disorders 1Agnosia 1

Interventions

Bupivacaine 4Saline Solution 3Ketamine 3Transcutaneous Electric Nerve Stimulation 2Ropivacaine 2Radiofrequency Ablation 2Magnesium Sulfate 2Ketorolac 2Dexmedetomidine 2Control Groups 2Anesthesia, Local 2Acupuncture Therapy 2Acetaminophen 2engage 8200 1Yoga 1Varenicline 1Transdermal Patch 1Therapeutics 1Telemedicine 1Surgical Instruments 1STAMP-I protocol 1Radiosurgery 1Psilocybin 1Palliative Care 1Oxycodone 1Music Therapy 1Morphine 1Methods 1Levobupivacaine 1Ketoprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Agnosia × Dipyrone × 1 year × Clear all
NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (OptalginĀ®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Rambam Health Care Campus

Phase NA Recruiting
30 enrolled

Agnosia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚔